Coagulation Disorders By Circulating Anticoagulants

Circulating anticoagulants are usually autoantibodies that certain clotting factors in vivo neutralize (z. B. a autoantibodies to factor VIII or factor V) or the phospholipidgebundene protein in vitro inhibit (antiphospholipid antibodies). The latter sometimes cause bleeding via a bond of in vivo prothrombin-phospholipid complexes. Circulating anticoagulants are usually autoantibodies that certain clotting factors in vivo neutralize (z. B. a autoantibodies to factor VIII or factor V) or the phospholipidgebundene protein…

September 3, 2018
Read More >>